New Medicines Restore Heart Function in 25 Percent of Heart Failure Patients
Nagpur: In a groundbreaking development, new medicines are helping 1 in 4 heart failure patients regain normal heart function, according to experts at the Annual ECHO Nagpur 2025 Conference.
"Heart failure is no longer a hopeless diagnosis. With modern treatments, we can now reverse the condition in about 25% of patients, restoring the heart's ability to pump blood efficiently. Additionally, in 50% of cases, heart failure can be managed effectively to improve quality of life," said Dr. JC Mohan, a leading cardiologist.
Heart failure, which affects nearly 1 crore adults in India, is often misunderstood. Unlike a heart attack, which occurs suddenly due to a blockage, heart failure develops gradually as the heart weakens over time. Sadly, it has a worse prognosis than many cancers, often going undiagnosed until it becomes severe.
Dr. Mohan emphasized the importance of early detection and treatment, which can extend patients' lives by six to eight years. Simple tests such as ECHO, ECG, and blood work can help identify heart failure early.
Dr. Vinod Vijan, former president of the Lipid Association of India, stressed the need for lower cholesterol levels among Indians due to their genetic vulnerability to heart diseases. He recommended aiming for cholesterol levels 10 points below global standards.
Dr. Shantanu Sengupta highlighted that awareness has grown significantly in the last two decades. Tools like 2D and 3D ECHO have become crucial in detecting early-stage heart problems, and he suggested people over 40 include these tests in regular health check-ups.
This breakthrough offers hope for millions, but experts caution that early diagnosis and lifestyle changes remain critical to combating heart failure effectively.
Looking for chemical products? Let suppliers reach out to you!
2026-07-17
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Zydus Lifesciences Blocked by Delhi High Court in Cancer Biosimilar Case $9.3 Billion Opdyta Patent Dispute Intensifies
-
Novartis Boosts 2025 Earnings Forecast as US Tariff Risks Loom $23 Billion Investment and $10 Billion Buyback Unveiled
-
Bristol Myers’ Reblozyl Misses Main Goal in Cancer Anemia Study $1.77 Billion Drug Faces Setback but Shows Some Benefits
-
Sanofi’s $2.2 Billion Dynavax Acquisition: Why Big Pharma Is Rebuilding the Global Vaccine Order
-
Sun Pharma’s Ilumya Hits Primary Endpoint in Two Phase 3 Trials for Psoriatic Arthritis $681 Million Drug Shows Significant Improvement at Week 24
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
McKinsey Pays to Close a Purdue Liability Chapter
Recommend Reading
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
Iran Conflict Leaves a Long Shadow on Drug Supply
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
Acrylic Prices Soar by Over 1 Year—Short-Term at High Levels, Medium-Term Under Pressure
-
Both Supply and Demand Surge, Formic Acid Prices Gradually Rise
-
March China Titanium Dioxide Market Prices Rise
-
Procter & Gamble Raises US Personal Care Prices Due to Tariff Pressure
-
Both Supply and Demand Tightening Drives Butadiene Prices Up Sharply in March